Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103705313> ?p ?o ?g. }
- W2103705313 endingPage "246" @default.
- W2103705313 startingPage "239" @default.
- W2103705313 abstract "Gefitinib (Iressa) is a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase. Recent studies confirmed that gefitinib interacted with the breast cancer resistance protein (BCRP) at submicromolar concentrations, whereas other multidrug transporters, including P-glycoprotein (P-gp), showed much lower reactivity toward gefitinib. Recently, many tracers for positron emission tomography (PET) have been prepared to study P-gp function in vivo; however, PET tracers had not been evaluated for both P-gp and BCRP modulation in the brain. Therefore, we evaluated in vivo brain penetration-mediated P-gp and BCRP in mice using [(11)C]gefitinib. Co-injection with gefitinib (over 50 mg/kg), a nonspecific P-gp modulator cyclosporin A (50 mg/kg), and the dual P-gp and BCRP modulator GF120918 (over 5 mg/kg) induced an increase in the brain uptake of [(11)C]gefitinib in mice 30 min after injection. In the PET study of mice, the radioactivity level in the brain with co-injection of GF120918 (5 mg/kg) was three- to fourfold higher than that in control after initial uptake. The radioactivity level in the brain in P-gp and Bcrp knockout mice was approximately eightfold higher than that in wild-type mice 60 min after injection. In conclusion, [(11)C]gefitinib is a promising PET tracer to evaluate the penetration of gefitinib into the brain by combined therapy with P-gp or BCRP modulators, and into brain tumors. Furthermore, PET study with GF120918 is a promising approach for evaluating brain penetration-mediated P-gp and BCRP." @default.
- W2103705313 created "2016-06-24" @default.
- W2103705313 creator A5000506509 @default.
- W2103705313 creator A5021026039 @default.
- W2103705313 creator A5021436025 @default.
- W2103705313 creator A5023878612 @default.
- W2103705313 creator A5030087345 @default.
- W2103705313 creator A5040184062 @default.
- W2103705313 creator A5055365794 @default.
- W2103705313 creator A5061406445 @default.
- W2103705313 creator A5064403117 @default.
- W2103705313 creator A5072866366 @default.
- W2103705313 creator A5076133971 @default.
- W2103705313 date "2009-04-01" @default.
- W2103705313 modified "2023-09-23" @default.
- W2103705313 title "In vivo evaluation of P-glycoprotein and breast cancer resistance protein modulation in the brain using [11C]gefitinib" @default.
- W2103705313 cites W1976550824 @default.
- W2103705313 cites W1979557679 @default.
- W2103705313 cites W1989070959 @default.
- W2103705313 cites W1993301860 @default.
- W2103705313 cites W2000751908 @default.
- W2103705313 cites W2001361864 @default.
- W2103705313 cites W2006434892 @default.
- W2103705313 cites W2007781906 @default.
- W2103705313 cites W2018959949 @default.
- W2103705313 cites W2020441233 @default.
- W2103705313 cites W2023493888 @default.
- W2103705313 cites W2036843484 @default.
- W2103705313 cites W2038603080 @default.
- W2103705313 cites W2049301565 @default.
- W2103705313 cites W2049938167 @default.
- W2103705313 cites W2054726524 @default.
- W2103705313 cites W2055903396 @default.
- W2103705313 cites W2062577889 @default.
- W2103705313 cites W2064437405 @default.
- W2103705313 cites W2076174476 @default.
- W2103705313 cites W2077541106 @default.
- W2103705313 cites W2079506644 @default.
- W2103705313 cites W2079648026 @default.
- W2103705313 cites W2079785947 @default.
- W2103705313 cites W2095670134 @default.
- W2103705313 cites W2096045848 @default.
- W2103705313 cites W2099335992 @default.
- W2103705313 cites W2101193630 @default.
- W2103705313 cites W2104135961 @default.
- W2103705313 cites W2111746410 @default.
- W2103705313 cites W2118207487 @default.
- W2103705313 cites W2118667947 @default.
- W2103705313 cites W2125589729 @default.
- W2103705313 cites W2130053145 @default.
- W2103705313 cites W2140744545 @default.
- W2103705313 cites W2142024216 @default.
- W2103705313 cites W2148467418 @default.
- W2103705313 cites W2151018358 @default.
- W2103705313 cites W2164188238 @default.
- W2103705313 cites W2188149910 @default.
- W2103705313 cites W43589343 @default.
- W2103705313 doi "https://doi.org/10.1016/j.nucmedbio.2008.12.006" @default.
- W2103705313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19324269" @default.
- W2103705313 hasPublicationYear "2009" @default.
- W2103705313 type Work @default.
- W2103705313 sameAs 2103705313 @default.
- W2103705313 citedByCount "59" @default.
- W2103705313 countsByYear W21037053132012 @default.
- W2103705313 countsByYear W21037053132013 @default.
- W2103705313 countsByYear W21037053132014 @default.
- W2103705313 countsByYear W21037053132015 @default.
- W2103705313 countsByYear W21037053132016 @default.
- W2103705313 countsByYear W21037053132017 @default.
- W2103705313 countsByYear W21037053132019 @default.
- W2103705313 countsByYear W21037053132022 @default.
- W2103705313 crossrefType "journal-article" @default.
- W2103705313 hasAuthorship W2103705313A5000506509 @default.
- W2103705313 hasAuthorship W2103705313A5021026039 @default.
- W2103705313 hasAuthorship W2103705313A5021436025 @default.
- W2103705313 hasAuthorship W2103705313A5023878612 @default.
- W2103705313 hasAuthorship W2103705313A5030087345 @default.
- W2103705313 hasAuthorship W2103705313A5040184062 @default.
- W2103705313 hasAuthorship W2103705313A5055365794 @default.
- W2103705313 hasAuthorship W2103705313A5061406445 @default.
- W2103705313 hasAuthorship W2103705313A5064403117 @default.
- W2103705313 hasAuthorship W2103705313A5072866366 @default.
- W2103705313 hasAuthorship W2103705313A5076133971 @default.
- W2103705313 hasConcept C104317684 @default.
- W2103705313 hasConcept C121608353 @default.
- W2103705313 hasConcept C126322002 @default.
- W2103705313 hasConcept C133936738 @default.
- W2103705313 hasConcept C149011108 @default.
- W2103705313 hasConcept C150903083 @default.
- W2103705313 hasConcept C170493617 @default.
- W2103705313 hasConcept C185592680 @default.
- W2103705313 hasConcept C207001950 @default.
- W2103705313 hasConcept C2778707650 @default.
- W2103705313 hasConcept C2778820342 @default.
- W2103705313 hasConcept C2779438470 @default.
- W2103705313 hasConcept C2780580887 @default.
- W2103705313 hasConcept C44312359 @default.
- W2103705313 hasConcept C501593827 @default.